Free tool
FAERS Monitor: Cortenema
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016199 or its brand name (Cortenema, Hydrocortisone). Reports on generic versions are filed under their own applications.
Reports
68,557
Serious
56,734
83% of reports
Hospitalization
29,145
Death reported
10,074
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use9,842
- drug ineffective7,713
- fatigue6,120
- condition aggravated5,620
- nausea5,204
- rash5,030
- headache4,607
- diarrhoea4,596
- pain4,578
- arthralgia4,418
- dyspnoea4,405
- pyrexia4,120
- vomiting4,011
- pruritus3,839
- malaise3,745
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 438 |
| 2005 | 559 |
| 2006 | 513 |
| 2007 | 549 |
| 2008 | 613 |
| 2009 | 738 |
| 2010 | 848 |
| 2011 | 1,086 |
| 2012 | 1,774 |
| 2013 | 1,547 |
| 2014 | 1,784 |
| 2015 | 2,446 |
| 2016 | 2,899 |
| 2017 | 3,325 |
| 2018 | 4,847 |
| 2019 | 4,344 |
| 2020 | 5,299 |
| 2021 | 5,541 |
| 2022 | 6,212 |
| 2023 | 6,140 |
| 2024 | 6,456 |
| 2025 | 6,261 |
| 2026 | 4,334 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,985,602 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| condition aggravatedSignal | 5,620 | 5.8 | 5.6 | 22,006 |
| pyrexiaSignal | 4,120 | 3.7 | 3.6 | 8,095 |
| rashSignal | 5,030 | 3.6 | 3.5 | 9,390 |
| off label useSignal | 9,842 | 3.5 | 3.4 | 17,908 |
| arthralgiaSignal | 4,418 | 3.3 | 3.2 | 7,082 |
| pruritusSignal | 3,839 | 3.1 | 3.0 | 5,455 |
| malaiseSignal | 3,745 | 2.6 | 2.6 | 3,841 |
| vomitingSignal | 4,011 | 2.6 | 2.6 | 4,112 |
| fatigueSignal | 6,120 | 2.4 | 2.4 | 5,267 |
| dyspnoeaSignal | 4,405 | 2.4 | 2.3 | 3,660 |
| painSignal | 4,578 | 2.3 | 2.2 | 3,423 |
| headacheSignal | 4,607 | 2.3 | 2.2 | 3,324 |
| diarrhoeaSignal | 4,596 | 2.2 | 2.1 | 3,054 |
| nauseaSignal | 5,204 | 2.0 | 2.0 | 2,782 |
| drug ineffective | 7,713 | 1.8 | 1.8 | 2,909 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.